Wiregene

Wiregene Co., Ltd. is a South Korean regenerative medical device company developing bioresorbable nerve guidance technologies for the treatment of peripheral nerve injuries and potential spinal cord regeneration applications. Founded in 2021, the company is advancing a proprietary multi-microchannel nerve conduit platform designed to guide directional axonal growth and support functional nerve recovery. Its bioresorbable polymer-based architecture incorporates thousands of aligned microchannels, providing a structured environment for nerve regeneration. Led by rehabilitation medicine specialists with extensive experience in nerve injury research, Wiregene has established preclinical proof-of-concept data in small and large animal models and is advancing its lead product toward clinical evaluation. The company aims to establish a differentiated alternative to conventional hollow nerve conduits while expanding into next-generation regenerative biomaterials and international medical devic